AS-CMC: a pan-cancer database of alternative splicing for molecular classification of cancer
Abstract Alternative splicing (AS) is a post-transcriptional regulation that leads to the complexity of the transcriptome. Despite the growing importance of AS in cancer research, the role of AS has not been systematically studied, especially in understanding cancer molecular classification. Herein,...
Main Authors: | Jiyeon Park, Jin-Ok Lee, Minho Lee, Yeun-Jun Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-25584-6 |
Similar Items
-
Identification of neoantigens derived from alternative splicing and RNA modification
by: Jiyeon Park, et al.
Published: (2019-08-01) -
RPS24 alternative splicing is a marker of cancer progression and epithelial-mesenchymal transition
by: Jiyeon Park, et al.
Published: (2024-06-01) -
Alternative Splicing for Diseases, Cancers, Drugs, and Databases
by: Jen-Yang Tang, et al.
Published: (2013-01-01) -
The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis
by: Liu Teng, et al.
Published: (2021-06-01) -
Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumors
by: Chen Duan, et al.
Published: (2023-09-01)